Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Bernd C Kieseier Xiaojun You Serena Hung Peter Calabresi |
| Publication date | February 10, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |